Related Experiment Video
Updated: Jun 11, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Quality indicators for care in juvenile idiopathic arthritis
Hend Alkwai1, Reem Alshammari2, Reem Abdwani3
1Department of Pediatrics, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.
Insights
A new set of 22 quality indicators (QIs) was developed to improve pediatric juvenile idiopathic arthritis (JIA) care in the Asia-Pacific region. These indicators focus on key domains to enhance patient outcomes.
Area of Science:
- Pediatric Rheumatology
- Healthcare Quality Improvement
- Asia-Pacific Health
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic condition affecting children, requiring specialized care.
- Improving the quality of care for JIA patients is crucial for optimal health outcomes.
- The Asia-Pacific region presents unique challenges in delivering consistent pediatric rheumatology care.
Purpose of the Study:
- To develop and validate a comprehensive set of quality indicators (QIs) for juvenile idiopathic arthritis (JIA) care.
- To tailor these QIs for the specific needs of children in the Asia-Pacific region.
- To establish a framework for evaluating and enhancing pediatric rheumatology services.
Main Methods:
- Adaptation of the RAND/UCLA Appropriateness Method (RAM).
- Systematic literature review to identify an initial 32 QIs.
- Delphi panel consensus involving pediatric rheumatologists and stakeholders from the APLAR-Pediatric SIG.
- Iterative voting rounds to refine and finalize QIs based on validity, reliability, and agreement.
Main Results:
- A final set of 22 quality indicators (QIs) for JIA care was established.
- The QIs are organized into six critical domains: access to care, clinical assessment, medication management, comorbidity screening, counseling, and patient satisfaction.
- The consensus process ensured the relevance and applicability of the QIs across the Asia-Pacific region.
Conclusions:
- The developed QIs provide a valuable tool for assessing and improving the quality of care for children with JIA.
- Implementation of these QIs can lead to enhanced health outcomes and more patient-centered care.
- These indicators support the goal of delivering specialized and effective healthcare for pediatric rheumatic diseases in the Asia-Pacific.
Objective:
To develop a set of quality indicators (QIs) tailored to improve the care provided to children with juvenile idiopathic arthritis (JIA) in countries across the Asia-Pacific region.
Methods:
An adaptation of the Research and Development Corporation (RAND)/University of California, Los Angeles (UCLA) Appropriateness Method (RAM) was used. An initial set of 32 QIs was developed after a systematic search of the literature. These were presented to members of a Delphi panel composed of pediatric rheumatologists and other relevant stakeholders from the Asia Pacific League of Associations for Rheumatology Pediatric Special Interest Group (APLAR-Pediatric SIG). After each round, the mean scores for validity and reliability, level of disagreement, and median absolute deviation from the mean were calculated.
Results:
The panelists were presented with 32 QIs in two rounds of voting, resulting in the formulation of a final set of 22 QIs for JIA. These QIs are categorized within six domains of care, including access to care, clinical assessment, medications and medication monitoring, screening for comorbidities, counseling, and self-efficacy and satisfaction with care.
Conclusion:
These QIs have been developed to evaluate and improve the quality of care provided to children with JIA, aiming to enhance health outcomes and ensure that healthcare services are tailored to the unique needs of this patient population.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Standards of Care I
Standards of Care II

